Clinical trials: Amnesia
Alzheimer's Disease, Dementia
A Study Of Oral PF-01913539 In Patients With Mild To Moderate Alzheimer's Disease
The purpose of this study is to demonstrate the safety and efficacy of PF-01913539 in the treatment of patients with mild-to-moderate Alzheimer's Disease.
- Conditions
- Alzheimer's Disease, Dementia, Dimebon, Investigational Drug
- Trial name
- NCT01066481
- Testing
- PF-01913539 5 mg
- Sponsor
- Pfizer
Mild Cognitive Impairment, Alzheimer Disease
Study of the Efficacy and Safety of Various Anti-inflammatory Agents in Participants With Mild Cognitive Impairment or Mild Alzheimer's Disease
The purpose of this platform study was to evaluate the effect of anti-inflammatory agents on cognition in early Alzheimer's disease.
- Trial name
- NCT04795466
- Testing
- Canakinumab
- Where
- 10 sites in United States, Finland and 2 more
- Volunteers
- 34 people
- Sponsor
- Novartis Pharmaceuticals
Falls (Accidents) in Old Age
FallsTalk Falls Prevention Program for Caregivers and Persons With Memory Loss or Dementia
This randomized-control trial involves dyads consisting of a family caregiver (CG) and a person with memory loss or dementia (PwD).
- Trial name
- FT-C (NCT03961386)
- Testing
- FallsTalk-C, FallsTalk
- Where
- United States
- Volunteers
- 100 people
- Sponsor
- Brookside Research & Development Company